[go: up one dir, main page]

AR070455A1 - Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas - Google Patents

Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas

Info

Publication number
AR070455A1
AR070455A1 ARP090100595A ARP090100595A AR070455A1 AR 070455 A1 AR070455 A1 AR 070455A1 AR P090100595 A ARP090100595 A AR P090100595A AR P090100595 A ARP090100595 A AR P090100595A AR 070455 A1 AR070455 A1 AR 070455A1
Authority
AR
Argentina
Prior art keywords
azatriciclicos
pharmaceutical compositions
bacterial infections
antibiotic compounds
compounds
Prior art date
Application number
ARP090100595A
Other languages
English (en)
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of AR070455A1 publication Critical patent/AR070455A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente se relaciona con compuestos antibacteriales de formula 1 en la cual n es 0 o 1; R1 representa H o F; U representa CH2 o, cuando n es 1, O o NH;ö-ô es un enlace o está ausente; V representa CH o N cuando ö-ô es un enlace, o CH2 o NH cuando ö-ôestá ausente; W representa CH o N; A representa -(CH2)p-NH-(CH2)q- en /// /// donde p es 1 y q es 1 o 2 o, cuando U representa CH2 y n es 1, p también puede ser 0 y q entonces es 2; G representa uno de los grupos de formulas (2) en donde Z representa N o CH y Q representa O o S; y Z0, Z1 y Z2 cada uno representa CH, o Z0 y Z1 cada uno representa CH y Z2 representa N, o Z0 representa CH, Z1 representa N y Z2 representa CH o N, o Z0 representa N y Z1 y Z2 cada uno representa CH; y con sales de tales compuestos.
ARP090100595A 2008-02-20 2009-02-20 Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas AR070455A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2008050603 2008-02-20
IB2008054065 2008-10-03

Publications (1)

Publication Number Publication Date
AR070455A1 true AR070455A1 (es) 2010-04-07

Family

ID=40986002

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090100595A AR070455A1 (es) 2008-02-20 2009-02-20 Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas

Country Status (14)

Country Link
US (1) US8349828B2 (es)
EP (1) EP2257551B1 (es)
JP (1) JP5349500B2 (es)
KR (1) KR101590202B1 (es)
CN (1) CN102015710B (es)
AR (1) AR070455A1 (es)
AU (1) AU2009215327A1 (es)
BR (1) BRPI0907892A2 (es)
CA (1) CA2713182C (es)
ES (1) ES2411930T3 (es)
MX (1) MX2010008922A (es)
RU (1) RU2010138648A (es)
TW (1) TW200940551A (es)
WO (1) WO2009104147A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0907892A2 (pt) 2008-02-20 2015-07-28 Actelion Pharmaceuticals Ltd Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo
CA2739373C (en) * 2008-10-07 2017-01-24 Christian Hubschwerlen Tricyclic oxazolidinone antibiotic compounds
EP2346862B1 (en) * 2008-10-10 2012-09-12 Actelion Pharmaceuticals Ltd. 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
EP2674430A4 (en) 2011-02-07 2014-07-02 Daiichi Sankyo Co Ltd AMINO-GROUP-PYRROLIDINONE DERIVATIVES
CN105949466A (zh) * 2011-06-30 2016-09-21 帝斯曼知识产权资产管理有限公司 含硅酮单体
CA2842885A1 (en) 2011-08-11 2013-02-14 Actelion Pharmaceuticals Ltd Quinazoline-2,4-dione derivatives
TW201326180A (zh) 2011-11-30 2013-07-01 Actelion Pharmaceuticals Ltd 3,7-二取代八氫-2H-吡啶并[4,3-e][1,3]□嗪-2-酮抗生素
WO2014024056A1 (en) 2012-08-06 2014-02-13 Daiichi Sankyo Company, Limited Pyrrolidine derivatives with antibacterial properties
JP6375365B2 (ja) 2013-04-16 2018-08-15 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd 抗菌活性を有する二芳香族誘導体
ITMI20131782A1 (it) * 2013-10-25 2015-04-26 Dipharma Francis Srl Procedimento per la preparazione di un agonista della trombopoietina
JP6112724B2 (ja) * 2013-10-31 2017-04-12 日本化薬株式会社 1,5−ナフチリジン誘導体およびそれを有効成分として含んでなる殺虫剤
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
JP7390728B2 (ja) * 2017-11-29 2023-12-04 バグワークス・リサーチ・インコーポレイテッド 抗菌複素環式化合物及びそれらの合成

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746987A (en) * 1980-09-05 1982-03-17 Mitsubishi Chem Ind Ltd 3,4-dihydrocarbostyril derivative and agricultural and horticultural germicide containing the same as active constituent
IT1212552B (it) 1982-10-20 1989-11-30 Italo Britannica L Manet Ti H Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica
US5298518A (en) * 1989-09-29 1994-03-29 Eisai Co., Ltd. Biphenylmethane derivative and pharmacological use
US5254682A (en) 1989-12-08 1993-10-19 Merck & Co., Inc. Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs
NZ334891A (en) 1996-10-24 2001-04-27 Novartis Ag Substituted aminoalkane phosphonic acids for treating block excitatory amino acid receptors related diseases
AU1026901A (en) 1999-10-29 2001-05-08 Syngenta Participations Ag Novel herbicides
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
WO2005016883A2 (en) 2003-08-14 2005-02-24 Icos Corporation Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
FR2873695A1 (fr) * 2004-07-30 2006-02-03 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
CA2572442A1 (fr) * 2004-07-30 2006-03-09 Palumed S.A. Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
WO2006032466A2 (en) 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
WO2006046552A1 (ja) 2004-10-27 2006-05-04 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
CN101258157A (zh) 2005-05-24 2008-09-03 阿斯利康(瑞典)有限公司 具有抗菌活性的氨基哌啶喹啉及其氮杂等构类似物
WO2007016610A2 (en) 2005-08-02 2007-02-08 Glaxo Group Limited Antibacterial agents
PT1954697E (pt) 2005-10-21 2010-05-17 Glaxo Group Ltd Compostos tricíclicos peri-condensados úteis como agentes antibacterianos
ES2344523T3 (es) 2005-12-22 2010-08-30 Glaxo Group Limited Compuestos heterociclicos, su preparacion y su uso como agentes antibacterianos.
JP2009526832A (ja) * 2006-02-14 2009-07-23 ファイザー・プロダクツ・インク 抗菌剤としてのベンゾオキサジノンおよびベンゾオキサゼピノンオキサゾリジノン
ATE469649T1 (de) 2006-03-23 2010-06-15 Actelion Pharmaceuticals Ltd Antibiotische cyclohexyl- oder piperidinylcarboxamid-derivate
DE602007009205D1 (de) 2006-04-06 2010-10-28 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
ATE522514T1 (de) 2006-06-16 2011-09-15 Pharma Mar Sa Dihydropyran-2-onverbindungen mit antitumorwirkung
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
TW200819457A (en) 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
US7977352B2 (en) 2006-12-01 2011-07-12 Galapagos Nv Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
CL2007003693A1 (es) 2006-12-22 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
EP2141154A4 (en) * 2007-03-30 2011-06-01 Inst Med Molecular Design Inc OXAZOLIDINONE DERIVATIVITY WITH HEMMETIC EFFECT ON TYPE I 11-HYDROXYSTEROIDDEHYDROGENASE
WO2008120003A1 (en) 2007-04-03 2008-10-09 Astrazeneca Ab Substituted piperidines for use in the treatment of bacterial infections
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
EP1980251A1 (en) 2007-04-13 2008-10-15 Glaxo Group Limited Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
SI2137196T1 (sl) 2007-04-20 2011-01-31 Glaxo Group Ltd Glaxo Welcome House Tricikliäśne spojine, ki vsebujejo duĺ ik, uporabne kot antibakterijska sredstva
GB0707706D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
GB0707708D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
WO2008150827A1 (en) 2007-05-29 2008-12-11 Smithkline Beecham Corporation Naphthyridine, derivatives as p13 kinase inhibitors
AR066879A1 (es) 2007-06-08 2009-09-16 Novartis Ag Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus
BRPI0812942B1 (pt) 2007-06-15 2018-11-21 Actelion Pharmaceuticals Ltd composto derivado de 3-amino-6 - (1-amino-etil) - tetra-hidropirano, composição farmacêutica e uso de referido composto.
EP2005995A1 (en) 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
KR101578234B1 (ko) 2007-12-18 2015-12-16 액테리온 파마슈티칼 리미티드 5-아미노시클릴메틸-옥사졸리딘-2-온 유도체
GB0800367D0 (en) 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds
BRPI0907892A2 (pt) 2008-02-20 2015-07-28 Actelion Pharmaceuticals Ltd Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo
JP5404652B2 (ja) 2008-02-22 2014-02-05 アクテリオン ファーマシューティカルズ リミテッド オキサゾリジノン誘導体

Also Published As

Publication number Publication date
CN102015710A (zh) 2011-04-13
BRPI0907892A2 (pt) 2015-07-28
JP2011512398A (ja) 2011-04-21
TW200940551A (en) 2009-10-01
KR20100124273A (ko) 2010-11-26
MX2010008922A (es) 2010-09-07
JP5349500B2 (ja) 2013-11-20
EP2257551A2 (en) 2010-12-08
WO2009104147A3 (en) 2009-11-05
RU2010138648A (ru) 2012-03-27
US20100331318A1 (en) 2010-12-30
CA2713182A1 (en) 2009-08-27
EP2257551B1 (en) 2013-04-10
ES2411930T3 (es) 2013-07-09
WO2009104147A2 (en) 2009-08-27
KR101590202B1 (ko) 2016-01-29
AU2009215327A1 (en) 2009-08-27
CN102015710B (zh) 2013-04-24
CA2713182C (en) 2016-09-13
US8349828B2 (en) 2013-01-08

Similar Documents

Publication Publication Date Title
AR070455A1 (es) Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas
CY1118199T1 (el) Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk
EA201070519A1 (ru) Соединения тропана
CR11861A (es) Compuestos organicos
NO20071880L (no) Diagnostic Compounds
UA112428C2 (uk) Пестицидні композиції і пов'язані з ними способи
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
EA201070786A1 (ru) Бензофуропиримидиноны
UY33921A (es) Oxazinopteridinas y oxazinoptiridinonas n-sustituidas
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
PE20080409A1 (es) Compuestos que modulan en el receptor cb2
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
UY31933A (es) Compuestos de sulfoximinamida para combatir plagas animales
CR10654A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
PA8855001A1 (es) Monocarbamas
ECSP10010664A (es) Derivados de urea heterocíclicos para el tratamiento de infecciones bacterianas
ATE478054T1 (de) Benzimidazolderivate
NO20085317L (no) Imidazoazepinonforbindelser
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
BR112012017188A8 (pt) composto agonista de mglu2, sua composição farmacêutica e seu uso
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
UY32247A (es) Nuevos compuestos de aminociclohexilo, composiciones farmacéuticas de los mismos y aplicaciones
UY30001A1 (es) Alquilsulfonamida quinolinas

Legal Events

Date Code Title Description
FB Suspension of granting procedure